Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Rallied Today

TheMotleyFool

0 0

Shares of Moderna (NASDAQ: MRNA) climbed 7.5% on Tuesday after health officials in the U.K. approved the drugmaker's COVID-19 vaccine for children ages 12 to 17.

The Medicines and Healthcare products Regulatory Agency (MHRA) issued a conditional approval for Moderna's vaccine, now called Spikevax, based on clinical trials that showed the drug to be safe and effective in kids 12 years of age and older.

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share